Timing is everything: brain energy metabolism in delirium
Age and Ageing · 04.05.2026 · 55 (5)
DOI: 10.1093/ageing/afag136 ↗Kurz gefasst
Editorial in der Zeitschrift Age and Ageing, online erschienen am 18.05.2026. Verfasst von Hannah A D Keage und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Adelaide University, Adelaide, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Australian Research Council.
Themen: Delir
Abstract (Originalsprache)
Editorial to accompany: New horizons: disrupted brain energy metabolism as a driver of delirium. Delirium reflects brain energy failure, but the timecourse of metabolic mechanisms remain poorly understood. Functional positron emission tomography enables measurement of glucodynamic variability and metabolic connectivity in individuals. Studying glucodynamics may clarify delirium mechanisms and guide treatments. Delirium remains common in older adults, signalling poor long-term clinical outcomes [1], yet its mechanistic underpinnings are poorly understood. Links between brain energy insufficiency and delirium have been recognised since the 1950s. Recent work by Sabharwal et al. [2] brings welcome renewed attention to cerebral energy metabolism in delirium and offers an opportunity to reconsider how we study brain energy failure in older people. The brain is critically dependent on a reliable and scalable supply of glucose to support its functions [3]. This means that glucose must be reliably supplied across the blood–brain barrier, and cerebral metabolism must be dynamically up- and down-regulated to meet the local energetic demands of neuronal function. Any disruption to the reliability or scalability of neural glucose can lead to brain disorders, including delirium. As such, to fully understand brain metabolism, we need both spatial and temporal information. To measure cerebral metabolism, the gold standard is [18F]-FDG-PET ([18F]-fluorodeoxyglucose positron emission tomography), a method that Sabharwal et al. [2] note typically has good spatial but poor temporal resolution—essentially equivalent to the 10–30 min scan duration. This gives researchers a static snapshot of what are highly dynamic cerebral metabolic processes. To fully understand the role of cerebral metabolism in delirium, it is therefore necessary to understand the spatial and temporal dynamics of glucose metabolism [4, 5]. Emerging FDG-PET methods with markedly improved temporal resolution, referred to as functional PET [6–8], offer a way to index cerebral glucose dynamics. These data can be acquired on standard PET/computed tomography or hybrid PET/magnetic resonance scanners with small modifications to image acquisition procedures [9]; specifically, the use of a bolus-infusion FDG administration protocol, and reconstruction of the images into consecutive short-duration frames. Functional PET opens up the ability to measure glucodynamics—the moment-to-moment variability in cerebral glucose metabolism—at rest and in response to tasks [7, 8, 10]. Glucodynamic timecourses have been mapped in the human brain with temporal resolutions as fast as 1 sec [11]. Functional PET therefore has considerable potential to advance the understanding of cerebral metabolic processes in delirium, including in individuals at risk and in examining its long-term neurophysiological consequences. Glucodynamic fluctuations are closely linked to age-related changes in cognition and brain organisation [10]. Healthy older adults show lower variability and complexity of glucodynamic timecourses than younger adults, accompanied by poorer cognitive performance and reduced efficiency of information transfer across functional brain networks [10, 12]. Whether delirium in older people is characterised by further reductions or even enhancements in glucodynamic activity has not yet been investigated. With the majority of the brain’s energy going toward maintaining spontaneous activity at rest, there appears to be an optimal glucodynamic range, which supports adaptive brain and behavioural responses [10]. It has been theorised that lower glucodynamic variability limits the brain’s ability to switch between functional brain networks, driven by lower coherent neural activity [10]. Although speculative, it could be hypothesised that hypoactive delirium symptoms may reflect lower glucodynamic variability while hyperactive symptoms reflect abnormally higher glucodynamic variability in resting states. These are precisely the sort of questions new functional PET techniques are poised to answer. Examining the coherence of glucodynamic signals across the brain delineates the brain’s metabolic network (or metabolic connectivity) [13]; enabling the characterisation of the energetic demands of the spatially distinct, but synchronised neuronal activity that underlies brain function. A recent pre-print reports four human brain metabolic connectivity networks [12], which may be key in explaining a proposed delirium-specific spatial pattern of cerebral metabolism involving hyper (sensorimotor and limbic) and hypo (frontoparietal, visual and frontal) metabolism [5]. More variable glucodynamics enables the brain to flexibly switch between different network configurations [10], and age-related reductions in glucodynamic variability reduces the number of network configurations that the brain can enter into. Exploring how the spatiotemporal organisation of cerebral metabolism varies between those with and without delirium, and in those at risk of delirium, would answer large gaps in delirium science. A key benefit of functional PET in this research space is that it allows metabolic networks to be mapped within individual people [rather than examining covariance between people (e.g. 5)], which would allow examination of the relationship between an individual’s delirium symptoms and metabolic network activity. Notably, within-individual metabolic networks can also be determined from classic bolus FDG-PET studies [14], opening opportunities to examine metabolic connectivity in delirium using legacy data as well. Lastly, these new functional PET methods may facilitate the development and testing of metabolic-related delirium prevention and treatment approaches such as intranasal insulin. In a recent trial, long-acting intranasal insulin (versus placebo) was related to reduced delirium duration in those ≤88 years of age, but not in those >89 years of age [15]. The authors hypothesised that these age-specific findings were related to changes in insulin resistance [15]. Marrying this up with functional PET work, it has been reported that both ageing and insulin resistance alter the rates of, and associations between, cerebral blood flow and glucose metabolism [16]. Functional PET may provide a sensitive tool to index the optimisation of brain energy metabolism to prevent and treat delirium. Preclinical studies combining functional PET with optogenetic approaches (e.g. 17), which allows pathways to be selectively activated or inhibited, could be particularly informative in delineating the directionality of relationships. Cumulative evidence suggests that cerebral metabolism is not merely a correlate but a key driver of delirium, with most existing work focused on where in the brain metabolic change occurs. Methodological advances now allow us to study when and how these changes unfold, opening the way to test whether fluctuations in cerebral energy metabolism are causally implicated in delirium risk, onset and resolution. For a field that has long recognised delirium as a disorder of brain energy failure, integrating temporal dynamics into our models is overdue and now methodologically possible. Glucodynamic metrics enable us to index how the brain adapts to changes in the environment and task demands, and how glucose use modifies resulting behaviour and cognition. We look forward to future studies applying these techniques to clarify the temporal dynamics of cerebral metabolism in delirium. None declared. S.D.J. is supported by the Australian Research Council (FT250100206).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Psychology, Adelaide University, Adelaide, Australia.
- School of Psychological Sciences & Monash Biomedical Imaging, Monash University, Melbourne, Australia.
ORCID-Profile: Hannah A D Keage, Sharna D Jamadar
Förderung
- Australian Research Council
Zitieren
APA
Keage, H. A. D., & Jamadar, S. D. (2026). Timing is everything: brain energy metabolism in delirium. Age and Ageing, 55(5). https://doi.org/10.1093/ageing/afag136
Vancouver
Keage HAD, Jamadar SD. Timing is everything: brain energy metabolism in delirium. Age and Ageing. 2026;55(5). doi:10.1093/ageing/afag136
BibTeX
@article{Keage2026,
author = {Keage, Hannah A D and Jamadar, Sharna D},
title = {Timing is everything: brain energy metabolism in delirium},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {5},
doi = {10.1093/ageing/afag136}
}
EUVIMED